跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 117 条关于
“mCNV”
全部
117
临床试验
89
药物
18
机构
0
资讯
10
去年
Sandoz's Aflibercept Biosimilar Afqlir Gains European Commission Approval
去年
European Commission Approves Sandoz's Afqlir, an Aflibercept Biosimilar, for Retinal Diseases
去年
European Commission Approves Sandoz's Afqlir® (aflibercept) Biosimilar for Retinal Diseases
去年
Sandoz's Afqlir (Aflibercept) Biosimilar Approved in Europe for Retinal Diseases
去年
Lupin Partners with SteinCares to Commercialize Ranibizumab Biosimilar Across Latin America
去年
Xbrane Resubmits Ranibizumab Biosimilar BLA to FDA Following Complete Response Letter
去年
FDA Sets October 2025 Decision Date for Xbrane's Ranibizumab Biosimilar Application
去年
Harrow Secures Exclusive US Rights to Samsung Bioepis Ophthalmology Biosimilars Portfolio
2年前
Minovia's MNV-201 Cell Therapy Shows Promise for Rare Pearson Syndrome Treatment
去年
Minovia Therapeutics Receives FDA Clearance for Phase Ib Trial of MNV-201 in Low-Risk MDS